News

Published on 12 Jan 2022 on Insider Monkey via Yahoo Finance

Hedge Funds Are Crazy About Axcelis Technologies Inc (ACLS)


Article preview image

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an individual investor’s stock selection process, as it may offer great insights of how the brightest minds of the finance industry feel about specific stocks. After all, these people have access to the smartest analysts and expensive data/information sources that individual investors can't match. So should one consider investing in Axcelis Technologies Inc (NASDAQ:ACLS)? The smart money sentiment can provide an answer to this question.

Axcelis Technologies Inc (NASDAQ:ACLS) investors should pay attention to an increase in hedge fund interest of late. Axcelis Technologies Inc (NASDAQ:ACLS) was in 22 hedge funds' portfolios at the end of September. The all time high for this statistic is 22. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that ACLS isn't among the 30 most popular stocks among hedge funds (click for Q2 rankings).

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium prices have more than doubled over the past year, so we go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. With all of this in mind let's review the recent hedge fund action encompassing Axcelis Technologies Inc (NASDAQ:ACLS).

NYSE.DOLE price evolution
NASDAQ.ACLS price evolution
NASDAQ.CSGS price evolution
NYSE.CRS price evolution
NYSE.PRO price evolution
NASDAQ.MLAB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Potentially Undervalued?

Mesa Laboratories, Inc. (NASDAQ:MLAB), might not be a large cap stock, but it led the NASDAQGS...

Simply Wall St. · via Yahoo Finance 6 Jan 2025

Analysis of Chuck Royce's Recent Transaction in Mesa Laboratories Inc

Overview of Chuck Royce (Trades, Portfolio)'s Recent Trade Warning! GuruFocus has detected 10 War...

GuruFocus.com · via Yahoo Finance 15 Oct 2024

The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable

Mesa Laboratories, Inc. (NASDAQ:MLAB) shareholders should be happy to see the share price up 12% ...

Simply Wall St. via Yahoo Finance 18 Apr 2024

Best Value Stocks to Buy for April 8th

Here are two stocks with buy rank and strong value characteristics for investors to consider toda...

Zacks via Yahoo Finance 8 Apr 2024

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Mesa Laboratories is US$189 based on 2 Stage Free Cash ...

Simply Wall St. via Yahoo Finance 7 Mar 2024

Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending

Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth...

Insider Monkey via Yahoo Finance 19 Feb 2024

Results: Mesa Laboratories, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

As you might know, Mesa Laboratories, Inc. (NASDAQ:MLAB) recently reported its quarterly numbers....

Simply Wall St. via Yahoo Finance 8 Feb 2024

Mesa Laboratories Inc (MLAB) Faces Revenue Dip Amidst Strategic Acquisitions

Revenue: Reported a slight decrease of 1.5% year-over-year to $53,473 thousand.Net Income: Experi...

GuruFocus.com via Yahoo Finance 5 Feb 2024

What Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Doing?

Mesa Laboratories, Inc. (NASDAQ:MLAB), is not the largest company out there, but it saw a decent ...

Simply Wall St. via Yahoo Finance 5 Jan 2024

Mesa Laboratories Inc (MLAB) Reports 9.5% Decrease in Q2 FY 2024 Revenues

Mesa Laboratories Inc (NASDAQ:MLAB) reports a 9.5% decrease in total revenues for Q2 FY 2024 comp...

GuruFocus.com via Yahoo Finance 7 Nov 2023